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Abstract 
Background:  Respiratory motion affects all tumor sites in the thorax and abdomen.  Variations 
of the respiratory pattern cause variations of the tumor motion which can result in differences 
between the planned and delivered dose distributions.  Previous breathing guidance techniques 
have been investigated to improve respiratory reproducibility; however, ventilation assistance has 
not been investigated.  We evaluated using bi-level positive airway pressure (BIPAP) ventilation 
assistance for improving respiratory reproducibility in patients with tumor sites impacted by 
respiratory motion. 
Methods:  Written informed consent was obtained for 10 patients currently undergoing radiation 
therapy treatment.  Patients participated in sessions over their course of treatment, which occurred 
either before or after their radiation treatments.  We collected and analyzed unassisted free-
breathing (FB) and BIPAP ventilation-assisted respiratory volume data using spirometry.  Patients 
used two BIPAP ventilators which both aimed to deliver the same volume of air each breath (i.e. 
tidal volume); however, one permitted patient triggering (i.e. permitted patients to initiate each 
breath) and the other did not.  Intra-session and inter-session variation metrics were calculated for 
each patient using the platform-specific (i.e. FB or BIPAP) tidal volumes.  We compared variation 
metrics between the platforms using the Wilcoxon signed-rank test, with a level of significance of 
0.05. 
Results: The BIPAP ventilator which permitted patient triggering was well tolerated; however, 
the other was not as well tolerated.  Both BIPAP ventilators significantly reduced the intra-session 
tidal volume variation (p = 0.022 and p = 0.007) compared to FB.  Neither of the BIPAP ventilators 
significantly reduced the inter-session tidal volume variation compared to FB (p = 0.203 and p = 
0.074).  
 viii 
Conclusions:  Based on the high correlation of tidal volume to tumor motion, any reduction of the 
tidal volume variation could result in a reduction of the tumor motion variation.  Future work will 
include an investigation into the possible clinical benefits of using BIPAP ventilation assistance to 
reduce tumor motion variations. 
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1. Introduction 
1.1. Background and Motivation 
1.1.1. Cancers Affected by Respiratory Motion 
Respiratory motion affects all organs in the thorax and abdomen.  Consequently, cancers 
located in these organs are affected by respiratory motion.  Lung cancer is the second most 
diagnosed cancer and the leading cause of cancer deaths, accounting for 25% of all cancer deaths 
in the U.S. in 2018.  An estimated 234,030 new cases were diagnosed in 2018, with an estimated 
154,050 deaths.  The five-year survival rate for all stages combined is only 18%.1  Depending on 
the stage of disease, treatment options include surgery, chemotherapy, or radiation therapy.  When 
patients are not suitable candidates for surgery due to existing health complications, radiation 
therapy, either alone or in combination with chemotherapy, is the preferred treatment option for 
lung cancer.2   
Treatment options for other cancers located in the thorax and abdomen, such as esophageal 
cancer or stomach cancer, also include radiation therapy.  External beam radiation therapy, where 
ionizing radiation is delivered from a linear accelerator to the patient, is the primary method for 
the treatment of these cancers.  The goal of external beam radiation therapy is to deliver radiation 
to cancerous tissues while minimizing radiation to surrounding healthy tissues and critical 
structures; however, achieving this goal can be difficult due to the influence of respiratory motion.   
1.1.2. The Mechanics of Breathing 
The lungs are paired, cone-shaped organs located in the thoracic cavity and are separated from 
each other by the heart and other structures of the mediastinum.  The primary function of the lung 
is to facilitate respiration or the exchange of gases (O2 and CO2) between the atmosphere and 
blood, thus maintaining normal levels of O2 and CO2 in the blood.  Respiration is an involuntary 
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action and takes place in three basic steps: pulmonary ventilation (exchange of gas between 
atmosphere and lungs), external respiration (exchange of gas between lungs and blood), and 
internal respiration (exchange of gas between blood and tissue cells).  Breathing is an important 
process of pulmonary ventilation and consists of the inhalation (breathing in) and exhalation 
(breathing out) of gas.  The nervous system, specifically the respiratory center located in the 
medulla oblongata and pons of the brain stem, usually controls breathing automatically to meet 
the body’s demand without conscious effort.  Because the cerebral cortex also has connections 
with the respiratory center, breathing can be controlled voluntarily for short periods of time.3 
Quiet or relaxed breathing requires the participation of respiratory muscles.  During inhalation, 
the diaphragm, which is a dome-shaped skeletal muscle that separates the thoracic and abdominal 
cavities, contracts and descends inferiorly.  The abdomen is forced inferiorly and anteriorly by the 
diaphragm, increasing the superior-inferior dimension of the thoracic cavity.  The external 
intercostal muscles, which connect adjacent ribs, also contract during inhalation.  This pulls the 
ribs superiorly and anteriorly, increasing both the anterior-posterior and lateral diameters of the 
thoracic cavity.  The lungs expand, increasing the lung volume, thus decreasing the pressure in the 
lungs below atmospheric pressure.  This pressure gradient between the atmosphere and lungs 
results in the flow of gas from the atmosphere to the lungs.  Exhalation is passive for quiet 
breathing.  The muscles of inhalation relax and the elastic lungs and thoracic walls return passively 
to their pre-inhalation positions, decreasing the lung volume, thus increasing the pressure in the 
lungs above atmospheric pressure.  This opposite pressure gradient results in the flow of gas from 
the lungs to the atmosphere.  Other respiratory muscles are involved only during labored 
exhalation.3 
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1.1.3. Problems of Respiratory Motion During Radiation Therapy 
Respiratory motion, which is a consequence of the mechanics of breathing, affects all tumor 
sites in thorax and abdomen.  Not accounting for respiratory motion can introduce problems or 
uncertainties during image acquisition, treatment planning, and radiation delivery.  It is important 
to note that respiratory motion is just one potential source of uncertainty in radiation therapy.  
Other sources of uncertainty include patient setup variations (inter-fraction motion) and inter-
observer variations in gross target volume (GTV) delineation.4   
Conventional image acquisition techniques used for tumor sites in the thorax and abdomen 
affected by respiratory motion can result in image artifacts.  Scalloping artifacts are commonly 
seen with helical computed tomography (CT) scans of the thorax (Figure 1.1.).  These artifacts 
manifest themselves as tumor/normal tissue delineation errors and can adversely affect dose-
calculation accuracy.4 
 
 
 Figure 1.1. Coronal view of a conventional CT scan of the thorax.  Note the scalloping artifacts 
at the right lung/diaphragm interface, circled in red.4 
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During treatment planning, different margins are added to the GTV to account for different 
uncertainties, ensuring coverage of the tumor during radiation delivery.  Using the International 
Commission on Radiation Units and Measurements (ICRU) 62 nomenclature, adding a margin to 
the GTV to include suspected microscopic spread creates the clinical target volume (CTV).5  The 
internal target volume (ITV) is obtained by adding additional margins to the CTV to account for 
intra-fraction tumor motion.  Additional margins to include setup uncertainties are added to the 
ITV to create the planning target volume (PTV).  Scalloping artifacts observed in conventional CT 
images of the thorax and abdomen, when respiratory motion is not accounted for, can make 
quantifying adequate margins difficult. 
 Radiation delivery for tumor sites impacted by respiratory motion can result in deviations 
between the planned and delivered dose distributions.  Intra-fraction tumor motion induced by 
respiratory motion causes an average or blurring of the dose distribution over the path of tumor 
motion while inter-fraction changes in respiratory motion cause a shift of the dose distribution.4  
These radiation delivery limitations can be exacerbated when respiratory motion is not accounted 
for during image acquisition and treatment planning. 
1.1.4. Respiratory Motion Management Strategies 
To reduce the impact of respiratory induced tumor motion, respiratory motion management 
strategies have been developed.  The American Association of Physicists in Medicine (AAPM) 
Task Group (TG) 76 report includes respiratory motion management strategies that can be applied 
during image acquisition, treatment planning, and radiation delivery.  A few strategies that are 
often utilized clinically are respiratory gating techniques, breath-hold techniques, and motion-
encompassing methods. 
Respiratory gating techniques involve administering radiation (during both image acquisition 
and radiation delivery) within a particular portion of the patient’s breathing cycle.  This portion or 
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window is often referred to as the “gate.”  The gate is usually chosen to extend over a region of 
the patient’s breathing cycle where the motion of the tumor is estimated to be less, which is 
generally end exhalation.  Tumor motion is typically monitored using a respiration surrogate signal 
such as an infrared reflector marker placed on the anterior abdominal surface or spirometry (i.e. 
air flow) measurements of the respiratory volume.  Vedam et al. reported a strong correlation (R2 
= 0.85) between the anterior abdominal surface position, midway between the xiphoid process and 
umbilicus, and the diaphragm position which is typically used as a surrogate for tumor postion.6  
In reality, there is the possibility that the surrogate for tumor motion does not accurately correspond 
to the time-dependent tumor position (Figure 1.2.).  This can result in radiation being delivered 
when the tumor is not within the gate.  The correlation between the tumor position and surrogate 
signal should always be verified prior to radiation delivery.7  
 
 
 Figure 1.2. Comparison of tumor position and an external respiration signal (anterior abdominal 
surface marker) for a patient with (A) no phase shift and (B) a phase shift during respiratory 
gating.  The dashed lines represent the gate and the orange lines represent the tumor’s position 
during a beam-on pulse.7 
 
Breath-hold techniques require that patients hold their breath during the administration of 
radiation (during both image acquisition and radiation delivery) and have predominately been 
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applied to breast cancer radiation therapy.  An external respiration signal (e.g. infrared abdominal 
reflector) is often used to monitor patient respiration, as well as provide visual feedback to the 
patient.  During image acquisition, patients receive verbal coaching and visual feedback of the 
external respiration signal to achieve and hold a reproducible inhalation state.  Patients are 
provided visual feedback of the external respiration signal and asked to achieve the same inhalation 
state during radiation delivery.  While breath-hold techniques aim to minimize respiratory motion 
during image acquisition and radiation delivery, they can be strenuous on patients, particularly in 
those with compromised respiratory function. 
Motion-encompassing methods involve scanning a region that includes the entire range of 
tumor motion during image acquisition and developing treatment volumes to encompass that range 
during treatment planning.  Treatment planning using motion-encompassing methods typically 
utilize a series of time-resolved three-dimensional CT images.4  This image acquisition technique, 
referred to as four-dimensional CT (4D CT), provides information on the mean tumor position, 
tumor range of motion, and tumor shape throughout the respiratory cycle (Figure 1.3.).  4D CT is 
accomplished by acquiring CT data in axial cine mode throughout the respiratory cycle at each 
scan location.  External respiration signals are simultaneously acquired during CT scanning using 
surrogate signals (e.g. infrared abdominal reflector).  To create the 4D CT image set, reconstructed 
CT images are retrospectively sorted into different spatially and temporally coherent volumes 
based on respiratory phase (e.g. 0%, 25%, 50%, 75%), which is obtained from the surrogate 
signal.8  A maximum intensity projection (MIP) image, or image displaying the maximum CT 
number found in a given voxel for all respiratory phases, can be created from the 4D CT image 
set.9  Other images created from the 4D CT image set include the minimum intensity projection 
image and average intensity projection image.  The MIP image is often used to obtain the 
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motion-encompassing ITV (Figure 1.4.).  Any variations of the respiratory patterns can increase 
the ITV, thus increasing the PTV.  Larger treatment volumes result in increased dose to 
surrounding normal tissues,9 which increases the risk of post-radiation complications such as 
radiation pneumonitis.10, 11   
1.1.5. Breathing Guidance Techniques 
Motion management strategies, specifically motion-encompassing methods, assume that 
patients will be breathing the same way during subsequent radiation delivery treatments as they 
were during image acquisition.  In reality, patients’ natural or free-breathing patterns can vary from 
breath to breath and day to day (Figure 1.5.).12-14  Both breath-to-breath and day-to-day breathing 
variations can cause tumor motion variations which can result in the tumor not being encompassed 
in the PTV during radiation delivery.  Therefore, tumor motion variations can result in differences 
between the planned dose distributions and the delivered dose distributions.   
 
 Figure 1.3. Isosurface renderings of CT data of a spherical object undergoing periodic motion 
during imaging.  Top row:  Examples of artifacts obtained by standard axial CT scanning, 
which depend on the interplay between CT data acquisition and object motion.  Bottom row:  
Left image shows CT scan of the static spherical object.  Other images show three positions (at 
different phases) of the moving object imaged with 4D CT.8 
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 Figure 1.4. Generating the motion-encompassing ITV from the maximum intensity projection 
(MIP) image.  (a) Schematic illustration of a mobile object imaged at four separate phases of 
motion.  (b) Coronal CT slice from one phase of 4D CT image set (e.g. 25%).  Lung tumor 
circled in red.  (c) ITV of schematic mobile object.  (d) Coronal CT slice of MIP image. 
 
 
 Figure 1.5. An example of free-breathing pattern variations for one patient recorded on two 
different days.  Breathing was monitored using an infrared abdominal surface reflector.  Note 
the variations in both the abdominal surface amplitude and period.12 
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Breathing guidance techniques, ranging from simple audio buzzers to providing visual 
feedback of the respiration signal, have been developed to reduce respiratory pattern variations, 
which in turn can improve image quality and radiation delivery accuracy.15  Kini et al. investigated 
using audio prompting and visual feedback, separately, as breathing guidance techniques on five 
patients.  Breathing was monitored and recorded using an infrared abdominal surface reflector.  A 
free-breathing recording was used as each patient’s control.  Audio prompting methods used 
instructions to “breath in” or “breath out” at periodic intervals which closely matched patients’ 
free-breathing patterns.  Visual feedback methods consisted of providing patients with a real-time 
trace of the abdominal surface reflector position.  The results of using audio prompting included a 
reproducible (i.e. less variation) period and a variable abdominal surface amplitude while the 
results of using visual feedback included a reproducible abdominal surface amplitude and a 
variable period (Figure 1.6.).  Kini et al. concluded that using some form of breathing guidance, 
either audio or visual, can improve patients’ respiratory reproducibility, compared to free-
breathing.12   
Most breathing guidance techniques use the anterior abdominal surface as a surrogate for the 
respiration signal; however, Lim et al. utilized respiratory volume, which has been shown to more 
highly correlate to tumor motion than the anterior abdominal surface.16  Lim et al. provided the 
real-time breathing pattern, monitored using a previously developed thermocouple respiratory 
monitoring mask, in addition to a breathing guidance curve, to ten healthy volunteers.  Their results 
included significant (p < 0.05) reductions in the standard deviations of the respiratory volume 
amplitudes and periods compared to free-breathing.17 
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 Figure 1.6. Breathing patterns using audio prompting and visual feedback as breathing guidance 
techniques on a single patient recorded on two different days.  The corresponding free-
breathing pattern for the same patient is shown in Figure 1.5.12 
 
Interest in breathing guidance techniques has increased with time since the early investigations 
by Kini et al. and Lim et al. (Figure 1.7.), mainly due to the advancements of radiation delivery 
techniques which require accurate tumor localization during image acquisition and treatment 
planning.15  Pollock et al. performed a systematic search of the current literature on breathing 
guidance techniques which yielded a total of 480 articles.  Only 27 of the 480 articles met their 
eligibility criteria for review, which consisted of a quantitative evaluation of the breathing 
guidance technique and included a control group.  In 21/27 studies, significant (p < 0.05) 
improvements using breathing guidance techniques were observed.15  These largely positive 
results warrant further studies to investigate and assess the possible clinical impact of using 
breathing guidance techniques. 
1.1.6. Continuous Positive Airway Pressure (CPAP) Ventilation 
Continuous positive airway pressure (CPAP) ventilation is a form of non-invasive ventilation 
that delivers a constant stream of pressurized air to the upper airways and lungs throughout the 
respiratory cycle.18  CPAP ventilation has safely been used for respiratory complications such as  
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 Figure 1.7. Breathing guidance studies published since 1994.  Note the increase of studies with 
time indicating a growing clinical interest.15 
 
obstructive sleep apnea, acute respiratory failure, and chronic obstructive pulmonary disease.19  
Functionally, CPAP ventilation increases the baseline lung volume (Figure 1.8.), compared to 
unassisted free breathing, which may improve lung compliance or the lung’s ability to stretch and 
expand.  This improvement in lung compliance decreases the work of breathing.20 
Recently, there has been some interest in using CPAP ventilation as a respiratory motion 
management strategy in radiation therapy.  Goldstein et al. investigated the effects of using CPAP 
ventilation on tumor motion, lung volume, and dose to critical organs in patients receiving 
stereotactic body radiation therapy for lung tumors.  10 patients underwent two 4D CT scans, one 
free-breathing and one using CPAP ventilation.  Tumor motion, lung volumes, and dose to critical 
organs was compared between the two scans.  Their results show that using CPAP ventilation 
significantly increased the total lung volume and reduced tumor motion, which contributed to 
reduced dose to the lungs and heart.21  The initial results of using CPAP as a respiratory motion 
management strategy are encouraging; however, Goldstein et al. utilized CPAP ventilation to 
increase the total lung volume to minimize tumor motion.  Improving patients’ respiratory 
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reproducibility cannot be accomplished with CPAP ventilation alone because it only provides a 
constant pressure throughout the respiratory cycle. 
 
 
 Figure 1.8. Example of CPAP ventilation.  Top: A constant stream of pressurized air is delivered 
to the upper airways and lungs throughout the respiratory cycle.  Bottom:  Example of a free-
breathe respiratory pattern (dashed line).  With CPAP ventilation (solid line), the baseline lung 
volume is increased and the respiratory pattern is relatively unchanged. 
 
1.1.7. Bi-Level Positive Airway Pressure (BIPAP) Ventilation 
Bi-level positive airway pressure (BIPAP) ventilation is another form of non-invasive 
ventilation and has been used for similar respiratory complications as CPAP ventilation.  BIPAP 
ventilation allows the independent adjustment of both the inhalation and exhalation pressures, as 
opposed to CPAP ventilation which only provides a constant pressure throughout the respiratory 
cycle.  BIPAP ventilators deliver a higher pressure during inhalation and lower pressure during 
exhalation (Figure 1.9.).  Functionally, BIPAP ventilation increases the baseline lung volume, 
compared to unassisted free breathing; however, the difference in positive pressures throughout 
the respiratory cycle provides greater assistance of patients’ breathing efforts, compared to CPAP 
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ventilation.22  Most commercially-available BIPAP ventilators offer volume-targeted modes, 
which aim to assist patients’ breathing efforts.22 
Volume-targeted modes deliver a preset volume of air each breath.  This volume of air each 
breath is referred to as the tidal volume.  Depending on the BIPAP ventilator, volume-targeted 
modes can be delivered using either a pneumatic blower ventilation system or a piston-driven 
ventilation system.  Volume-targeted modes may or may not permit patient-triggering.  Patient-
triggering allows patients to initiate or trigger each breath as well as control their tidal volume each 
breath.  Volume-targeted modes that do not permit patient-triggering offer the most control of the 
tidal volume and breathing period while still assisting patients’ breathing efforts.22  BIPAP 
ventilation assistance using a volume-targeted mode could improve patients’ respiratory 
reproducibility.   
1.1.8. Research Motivation 
BIPAP ventilation assistance has not been investigated as a technique to improve patients’ 
respiratory reproducibility in the radiation therapy setting.  Volume-targeted BIPAP ventilation 
assistance has added advantages, compared to free-breathing and CPAP ventilation, of assisting 
patients’ respiratory patterns and delivering a preset tidal volume each breath.  Based on the high 
correlation of tidal volume to tumor motion,16 improving patients’ respiratory reproducibility 
could ultimately improve tumor motion reproducibility.  We hypothesized that candidates for 
BIPAP ventilation assistance will show improved respiratory reproducibility both breath to breath 
and day to day.  To test this hypothesis, we used two different BIPAP ventilators, both with 
volume-targeted modes.  We collected breathing data on a sample of patients currently undergoing 
radiation therapy treatment during sessions throughout their course of treatment. 
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 Figure 1.9. Example of BIPAP ventilation.  Top:  A higher pressure is delivered during inhalation 
and a lower pressure is delivered during exhalation.  Bottom:  Example of a free-breathe 
respiratory pattern (dashed line).  With BIPAP ventilation (solid line), the baseline lung volume 
is slightly increased and the respiratory pattern is optimally assisted.  An ideal, reproducible 
respiratory pattern would be consistent in both the tidal volume and period each breath. 
 
1.2. Hypothesis and Specific Aims 
We hypothesized that candidates for BIPAP ventilation assistance will show significantly 
reduced (p < 0.05) intra-session and inter-session tidal volume variation compared to unassisted 
free-breathing.  To test our hypothesis, we developed the following aims: 
Aim 1:  Modifications of equipment needed for this study. 
Aim 2:  Collect and evaluate patients’ free-breath data. 
Aim 3:  Collect and evaluate patients’ BIPAP ventilation-assisted data.  
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2.  Methods and Materials 
2.1. Aim 1: Equipment Modifications 
2.1.1. Aim 1 Overview 
In this aim, we modified equipment needed for this study.  Modifications included extracting 
data from one of the BIPAPs, adapting the other BIPAP for exhalation, and developing a method 
for the tracking of an abdominal surface marker. 
2.1.2. BIPAP Ventilators Used in this Study 
We utilized two different commercially-available BIPAP ventilators in this study; the Philips 
BIPAP and the Lifecare BIPAP.  Both ventilators provided volume-targeted ventilation assistance; 
however, the Philips BIPAP permitted patient triggering while the Lifecare BIPAP did not. 
The Philips Respironics V60 BIPAP ventilator is a microprocessor-controlled pneumatic 
blower ventilation-assistance system (Philips Respironics California, LLC., Carlsbad, CA).  The 
Philips BIPAP (Figure 2.1.) offers a volume-targeted mode named the average volume-assured 
pressure support (AVAPS) mode.  The AVAPS mode maintains a target tidal volume each breath 
by monitoring previous tidal volumes and continuously adjusting the delivered pressures.  An 
important characteristic of the Philips BIPAP is the “Auto-Trak Sensitivity,” which is its ability to 
recognize and compensate for unintentional leaks in the patient circuit system.  The output air from 
the Philips BIPAP exits the ventilator through the patient air outlet and into the patient circuit, 
which consists of a six-foot-long, ¾" diameter, piece of flexible plastic tubing connected to the 
patient’s ventilation mask.  The user interface includes a color LCD touchscreen which displays 
monitored patient parameters, as well as the real-time pressure, flow, and volume waveforms 
(Figure 2.1.).  The Philips BIPAP provides pure ventilation assistance, meaning that both the 
volume of air output by the ventilator and the initiation of each breath is determined by the patient 
(i.e. permits patient triggering).   
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 Figure 2.1. Left:  Philips Respironics V60 BIPAP ventilator.  Right:  Philips BIPAP LCD 
touchscreen which displays monitored patient parameters such as the tidal volume and 
breathing period as well as the real-time pressure, flow, and volume waveforms. 
 
 The Lifecare Personal Lightweight Ventilator (PLV) 100 is a microprocessor-controlled, 
piston-driven ventilation assistance system (Respironics, Inc., Murrysville, PA).  Unlike the 
Philips BIPAP, the Lifecare BIPAP (Figure 2.2.) offers a Control mode which is a volume-targeted 
mode that does not permit patient triggering.  The Control mode delivers all breaths at a preset 
tidal volume and breathing period.  Similar to the Philips BIPAP, the output air from the Lifecare 
BIPAP exits the ventilator through the patient air outlet and into the patient circuit.  The front panel 
includes digital displays of user-selected settings (e.g. tidal volume), which are controlled by 
associated knobs.  The Lifecare BIPAP provides controlled ventilation assistance, meaning that 
both the volume of air output by the ventilator and the start of each breath is determined by the 
ventilator (i.e. does not permit patient triggering).   
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 Figure 2.2. Lifecare PLV-100 BIPAP ventilator. 
 
2.1.3. Extracting Philips BIPAP Volume Waveform Data 
 The Philips BIPAP ventilator provides a color LCD touchscreen that displays monitored 
patient parameters, in addition to the real-time volume waveforms (Figure 2.1.).  The real-time 
volume waveform is continuously updated and resets to zero after 24 seconds has expired.  
Unfortunately, the volume waveform data displayed by the ventilator could not be easily retrieved 
due to manufacturer limitations.  As a result, we extracted the Philips BIPAP volume waveforms 
by recording the real-time volume waveform and post-processing the video using in-house 
developed video analysis code. 
We built a custom camera mount to record the real-time volume waveform.  We used foam, 
an 1/8" acrylic sheet, and bar clamps to build the camera mount that clamped to the Philips BIPAP.  
An IPEVO® Ziggi-HD USB document camera (IPEVO, Sunnyvale, CA) was attached to the 
camera mount using mini bar clamps and a C-clamp (Figure 2.3.).  The camera was connected to 
a dedicated computer which contained the camera’s software, IPEVO Visualizer, and was used to 
record the Philips BIPAP volume waveforms.   
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 Figure 2.3. Camera attached to the custom camera mount on the Philips BIPAP. 
 
In-house MATLAB® (The MathWorks, Inc., Natick, Massachusetts, US) video analysis code, 
utilizing Canny edge detection, was written to extract the Philips BIPAP displayed volume 
waveforms from the recorded videos (Figure 2.4.).  We validated our extracted volume values to 
the displayed Philips BIPAP volume values.  The Philips BIPAP volume values were acquired by 
freezing the waveform and sliding a provided cursor along the waveform.  Eight volume 
waveforms were recorded and analyzed.  Each volume waveform was created manually using a 
silicone lung phantom connected to the Philips BIPAP.  Statistically significant differences 
between the extracted volume values and Philips BIPAP displayed volume values were tested 
using the parametric Student’s paired t-test, with a level of significance of 0.05. 
2.1.4. Adapting Lifecare BIPAP to Permit Patient Exhalation 
Unlike the Philips BIPAP, the Lifecare BIPAP contains multiple one-way airflow valves which 
do not permit patient exhalation through the patient circuit and back into the ventilator.  To permit 
patient exhalation, we developed an in-house exhalation valve that we inserted into the patient 
circuit.  We utilized a one-way Adafruit 12V plastic water solenoid valve to permit patient 
exhalation through the patient circuit and a plastic Y-valve to allow the valve to be inserted into  
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 Figure 2.4. Screenshot of the real-time volume waveform displayed by the Philips BIPAP.  The 
corresponding edge detection image and extracted waveform are also shown, which were 
produced from in-house MATLAB® video analysis code.  Tidal volume peaks are shown in the 
extracted waveform as black stars. 
 
the patient circuit (Adafruit Industries, New York City, NY).  Both had ¾" (outer diameter) outlets, 
which allowed the valves to be inserted into the patient circuit without any modifications (Figure 
2.5.).  The water solenoid valve, which was normally closed, was opened by applying 12 volts 
(from an external battery), direct current, across two power terminals.  Electronic timing was used 
from the Lifecare BIPAP to synchronize the open/closed states of the valve with the air volume 
output of the ventilator.   
2.1.5. Developing a Method for Tracking an Abdominal Surface Marker 
As previously mentioned, respiratory motion is often monitored using respiration surrogate 
signals such as spirometry measurements of the tidal volume or the tracking of an anterior 
abdominal surface marker.  We wanted to use the tracking of an anterior abdominal surface marker 
to provide a monitoring system that was independent of the tidal volume measurements and 
consistent across both the free-breathing and BIPAP ventilation data collection platforms. 
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 Figure 2.5. One-way water solenoid valve and Y-valve inserted into the Lifecare BIPAP patient 
circuit to permit patient exhalation. 
 
We developed an in-house method for the tracking of an anterior abdominal surface marker.  
We used an abdominal compression frame, ½" acrylic sheet, foam, wood, hex bolts, and a heavy-
duty plastic stick and associated track to build a custom abdominal surface marker system (Figure 
2.6.).  Circular reflectors (1 cm diameter) were glued along the plastic stick, which was used as 
the abdominal surface marker.  A 12-megapixel iPhone 6s, positioned between the two blue foam 
pieces, was used to record the abdominal surface marker motion at 30 frames per second (Apple 
Inc., Cupertino, CA).  In-house PythonTM (Python Software Foundation, Beaverton, Oregon, US) 
video analysis code was written to track the circular reflectors on the abdominal surface marker.  
We validated the tracked positions of the circular reflectors using the Quality Assurance System 
for Advanced Radiotherapy (QUASAR) Respiratory Motion Phantom, which provided a stage that 
oscillated with a manufacturer stated 10 mm amplitude, at a user-selected rate (4-60 breaths per 
minute).   
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To verify reproducibility, we recorded eight 5-minute sessions, using different rates of the 
QUASAR phantom and different tracked circular reflectors.  The abdominal surface marker rested 
on the oscillating stage of the QUASAR phantom.  Reproducibility was quantified using the 
standard deviation of the abdominal surface marker amplitudes for all eight sessions. 
2.2. Aims 2 & 3: Collect and Evaluate Patients’ Free-Breathe (FB) & BIPAP Data 
2.2.1. Institutional Review Board Approval and Patient Enrollment 
We obtained institutional review board (IRB) approval from Our Lady of the Lake (OLOL) 
College in March of 2018 (OLOL IRB #2018-029).  The IRB protocol (Appendix A. Institutional 
Review Board Protocol) consisted of collecting patients’ breathing data with and without BIPAP 
ventilation assistance during daily sessions, either before or after their radiation treatments.  
Written informed consent was obtained for all patients on their initial imaging simulation day.  
Candidates for BIPAP ventilation assistance included patients that met the following criteria:  
 
 Figure 2.6. Custom built abdominal surface marker system.  The abdominal surface marker 
(plastic stick) rested on the patient’s anterior abdominal surface.  The abdominal surface 
marker’s motion was recorded with an iPhone, which was positioned between the two blue 
pieces of foam. 
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• Presented at Mary Bird Perkins Cancer Center’s Essen Lane location for fractionated 
radiation therapy with disease sites impacted by respiratory motion (e.g. lung cancer and 
esophageal cancer); 
• Were to be treated with normal breathing during treatment (i.e. non-breath-hold patients); 
• Were able to tolerate wearing a nasal ventilation mask; 
• Were able to breathe through their nose only for at least two-minute intervals; and 
• Were amenable to coaching for their breathing. 
Eleven patients were initially enrolled in this research study and were fitted with a nasal 
ventilation mask and bacteria filter (Figure 2.7.); however, one patient was excluded from this 
study because they could not breathe through their nose.  We collected free-breathe and BIPAP 
data from the remaining 10 patients during sessions which occurred either before or after patients’ 
radiation treatments and lasted 10-15 minutes.  
 
 
 Figure 2.7. Left:  Bacteria filter.  Right:  Nasal ventilation mask with black Velcro® straps. 
 
 The patient characteristics (Table 2.1.) included a mean age of 58 years and range of 34-75 
years.  Three patients received 28 radiation treatment fractions for esophageal cancer.  Five patients 
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received 30-33 radiation treatment fractions for lung cancer.  The remaining two patients received 
four and seven stereotactic body radiation treatment fractions for lung cancer.  All patients had a 
smoking history, which ranged from an unknown amount of pack-years to 90 pack-years (1 pack-
year = 7300 cigarettes).  All patients had sessions on more than 50% of their treatment days.   
 
Patient Age (years) Gender 
Treatment 
Site 
Smoking 
History 
Treatment 
Fractions Sessions 
1 57 M Esophageal ‡ 28 25 
2 61 M RLL ‡ 30 21 
3 75 M RUL † 33 17 
4 57 M Esophageal † 28 16 
5 59 F RLL ‡ 33 17 
6 66 M LL U 30 18 
7 43 F RUL † 33 17 
8 71 M Esophageal † 28 15 
9 34 M LLL † 4 4 
10 52 F LL † 7 4 
Abbreviations:  RLL = right lower lung; RUL = right upper lung; LL = left lung; LLL = left lower lung 
†:  < 30 pack-years 
‡:  31-90 pack-years 
U:  Unknown pack-years 
1 pack-year = (1 pack/day)*(20 cigarettes/pack)*(365 days/year)*(1 year) = 7300 cigarettes 
 
2.2.2. FB Data Collection 
Free-breathe (FB) data, which included the FB tidal volume data and FB abdominal surface 
marker data, was recorded at the beginning of patients’ sessions.  Patients first put on their nasal 
ventilation mask and bacteria filter, and then were immobilized using the same devices created 
during their initial imaging simulation.  Patients were not asked to remove any clothing.  The 
abdominal surface marker system was positioned such that the marker, which rested on a 1" x 2" 
x 1/8" (width x length x thickness) acrylic sheet, was midway between the xiphoid process and the 
umbilicus.  Indexing on the couch was used to ensure abdominal surface marker placement 
 Table 2.1. Patient characteristics. 
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reproducibility for each session.  The seal of patients’ ventilation masks was checked by having 
patients forcefully exhale through their nose and blocking the mask outlet.  This process was 
repeated until the patient and investigator were satisfied that the mask was not leaking (i.e. no 
audible leak and patient could not feel any air leaking).   
Components of the FB data that were analyzed included the tidal volumes, and the abdominal 
surface marker amplitudes, periods, and baselines (Figure 2.8.).  FB tidal volume data was 
recorded using a mass flow meter, which uses complementary metal-oxide-semiconductor 
technology to measure air flow at rates up to 200 standard liters per minute (slm) and with an 
accuracy of ± 0.05 slm (Sensirion AG, Switzerland).  The SFM 3000 flow meter (Figure 2.9.), 
with a vendor supplied adapter cable and USB stick, was connected to the same dedicated 
computer as the camera used to record the Philips BIPAP volume waveforms.  The sensor’s 
software sampled the air flow approximately every eight milliseconds and logged the flow signal 
in a comma separated variable file.  The tidal volume data, which is simply the integrated flow 
signal, was calculated using in-house developed MATLAB® code (Appendix B. Calculating 
Volume from Flow Signal). The flow meter, which had ¾" outlets, was coupled to patients’ 
bacteria filters.  Patients were instructed to breathe through their nose only for two minutes, 
simulating a typical volumetric modulated arc therapy (VMAT) radiation treatment beam-on 
time,23 and were notified when the FB data collection began.  
2.2.3. BIPAP Ventilator Settings 
The Philips BIPAP ventilator settings and Lifecare BIPAP ventilator settings were determined 
during patients’ first sessions.  Patient-specific ventilator settings were set to closely match 
patients’ natural free-breathing patterns.  Patients were asked to provide verbal feedback during 
this process to assist with any fine tuning of the ventilator settings. 
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 Figure 2.8. An example of collected free-breath data.  Top:  Plot of volume as a function of time 
with the tidal volume of each breath indicated by the black stars.  Bottom:  Plot of abdominal 
surface marker position as a function of time.  The amplitude of each breath is indicated by the 
blue lines.  The baseline, or starting position of each breath, is indicated by the green stars.  The 
period, or time between adjacent peaks, is indicated by the T.  Patients were instructed to take 
a large breath at the end of the data recording.  We used this large breath to synchronize the 
volume plot and abdominal surface marker position plot (i.e. time = 0).  Similar data was 
collected using the Philips BIPAP and Lifecare BIPAP. 
 
 
 
 
 Figure 2.9. Sensirion SFM 3000 mass flow meter. 
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The Philips BIPAP aimed to maintain a target tidal volume each breath by monitoring previous 
tidal volumes and continuously adjusting the delivered pressures.  The tidal volume was the only 
ventilator setting that needed to be determined since the Philips BIPAP permitted patient 
triggering.  During the first session, following the FB data collection, patients were connected to 
the Philips BIPAP to introduce them to BIPAP ventilation.  Patients were asked to establish a 
natural breathing pattern.  Inhalation and exhalation maximum pressures were limited to 8 cmH20 
and 4 cmH20, respectively.  After patients felt comfortable with BIPAP ventilation assistance 
(usually a few minutes) a target tidal volume was set, which was determined from the mean tidal 
volume from the FB data collection.  Patient feedback was then used to adjust the tidal volume.  
The Lifecare BIPAP delivered a preset tidal volume at a fixed breathing period.  Both the tidal 
volume and breathing period ventilator settings needed to be determined since the Lifecare BIPAP 
did not permit patient triggering.  During the first session, following the Philips BIPAP data 
collection, patients were connected to the Lifecare BIPAP.  The same tidal volume was used as 
the Philips BIPAP.  The breathing period was determined from the mean breathing period 
calculated from the FB data collection.  The Lifecare BIPAP ventilator settings were fine-tuned 
using patient feedback.   
2.2.4. Philips BIPAP Data Collection 
The Philips BIPAP provided pure ventilation assistance (i.e. permitted patient triggering) 
which required patients to actively control their breathing to improve their respiratory 
reproducibility.  We provided patients with visual feedback of their real-time volume waveform 
when using the Philips BIPAP.  A projector was mounted to the patient couch and aimed at the 
ceiling directly above patients’ heads (Figure 2.10.).  The real-time volume waveform, captured 
by the camera mounted to the Philips BIPAP, was fed from the dedicated computer to the projector.  
A dotted line at the level of the target tidal volume was superimposed on the volume waveform 
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(Figure 2.4.).  Patients were instructed to inhale to the dotted line and then exhale.  The Philips 
BIPAP continuously adjusted the applied pressures to assist patients in achieving the target tidal 
volume each breath. 
After the completion of the FB data collection, patients were connected to the Philips BIPAP 
using the appropriate patient-specific settings.  The flow meter that was used during the FB data 
collection was removed from the patient circuit.  It could not be used with the Philips BIPAP 
because the BIPAP continuously adjusted the delivered pressures to maintain the target tidal 
volume (i.e. the flow signal baseline was continuously changing).  After a short warm-up period 
(10-90 seconds), patients were notified that the Philips BIPAP data collection would begin and 
last two minutes.  Components of the Philips BIPAP data that were analyzed included tidal 
volumes, and abdominal surface marker amplitudes, periods, and baselines (Figure 2.8.). 
 
 
 Figure 2.10. Left:  Projector aimed at the ceiling directly above patients’ heads.  Right:  Example 
of the real-time volume waveform that was provided to patients. 
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2.2.5. Lifecare BIPAP Data Collection 
The Lifecare BIPAP provided controlled ventilation assistance (i.e. did not permit patient 
triggering) which required patients to synchronize their breathing with the air volume output of 
the Lifecare BIPAP to improve their respiratory reproducibility.  We provided patients with 
inhalation and exhalation visual cues when using the Lifecare BIPAP.  We built a visual cue stand 
that clamped to the couch and hung above patients’ heads (Figure 2.11.).  The visual cue stand 
contained a green “inhale” LED and a red “exhale” LED.  The same electronic timing as the 
exhalation valve was used to synchronize the inhale and exhale LEDs with the air volume output 
of the Lifecare BIPAP.  Patients were instructed to inhale when the green LED was illuminated 
and exhale when the red LED was illuminated. 
The order of the Philips BIPAP and Lifecare BIPAP was switched daily to mitigate any 
potential bias of using the BIPAPs in the same order.  After the completion of either the FB data 
collection or Philips BIPAP data collection, patients were connected to the Lifecare BIPAP, using 
the appropriate patient-specific ventilator settings. The flow meter that was used during the FB 
data collection was inserted into the patient circuit.  After a short “warm-up” period (10-90 
seconds), patients were notified that the Lifecare BIPAP data collection would begin and last two 
minutes.  Components of the Lifecare BIPAP data that were analyzed included tidal volumes, and 
abdominal surface marker amplitudes, periods, and baselines (Figure 2.8.). 
2.2.6. Data Analysis 
After each session for a single patient, we calculated a mean and standard deviation for each 
component of the FB data, Philips BIPAP data, and Lifecare BIPAP data.  Data components of 
each platform (i.e. FB, Philips BIPAP, and Lifecare BIPAP) included the tidal volumes, and 
abdominal surface marker amplitudes, periods, and baselines (Figure 2.8.).  Variations of each 
platform-specific data component for each session were quantified using a variation metric, which 
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 Figure 2.11. Left:  Visual cue stand hanging above patient’s head.  Right:  Visual cue stand 
which contained a green “inhale” LED and a red “exhale” LED. 
 
was either the coefficient of variation (CV), which is simply the ratio of the standard deviation to 
the mean, or the standard deviation (SD).   
We defined intra-session variation for each platform-specific data component as the mean 
variation metric for that platform-specific data component of all sessions.  We defined inter-
session variation for each platform-specific data component as the CV of the platform-specific 
data component session means. This intra-session and inter-session analysis process was repeated 
for all patients (Table 2.2.). 
 
Platform-Specific Data 
Component 
Intra-Session Variation 
Metric 
Inter-Session Variation 
Metric 
Tidal Volume CV CV 
ASM◊ Amplitude CV CV 
ASM◊ Period CV CV 
ASM◊ Baseline SD  
◊ Abdominal Surface Marker (ASM) 
CV = Coefficient of Variation 
SD = Standard Deviation 
 Table 2.2. Summary of variation metrics for each platform-specific (i.e. FB, Philips BIPAP, 
Lifecare BIPAP) data component.  Variation metrics were calculated for each patient. 
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The intra-session variation metric for the abdominal surface marker baseline was defined 
differently than the other data components.  The mean abdominal surface marker baseline position 
does not provide any useful information, meaning we were only interested in the variation of the 
baseline, not the location in space around which that baseline variation was averaged.  As a result, 
we used the SD of the abdominal surface marker baselines, rather than the CV, as the intra-session 
variation metric.  We also could not calculate an inter-session variation metric for the abdominal 
surface marker baselines because we did not have a reliable method for monitoring the baseline 
session to session.  For example, if a patient wore a thick sweatshirt during one session and did 
not wear the same sweatshirt during another session, then the mean abdominal surface marker 
baseline would be different session to session because of patient clothing.   
We compared the variation results of each data component for all patients between platforms 
(i.e. FB vs. Philips BIPAP, FB vs. Lifecare BIPAP, Philips BIPAP vs. Lifecare BIPAP).  Statistical 
significance was determined for each comparison using the non-parametric Wilcoxon signed-rank 
test, with a significance level of 0.05, based on the small number of samples and a visual inspection 
of the data distributions. 
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3. Results 
3.1. Aim 1 Results: Equipment Modifications 
3.1.1. Extracting Philips BIPAP Volume Waveform Data 
Eight volume waveform videos, each 24 seconds, were recorded and analyzed to validate the 
extracted volume values.  100 extracted volume values were compared to the displayed Philips 
BIPAP volume values.  No significant difference (p = 0.533) was found between the extracted 
volume values and Philips BIPAP volume values.  The mean relative percent difference ([extracted 
value – Philips value]/Philips value) was -1.46% (Figure 3.1.), which corresponded to a mean 
absolute percent difference of 3.80%.   
 
 
 Figure 3.1. Histogram of the percent differences between the extracted volume values and 
Philips BIPAP displayed volume values.  The two most negative bins correspond to small 
differences with small Philips BIPAP volume values (e.g. a difference of ~10 mL with a Philips 
BIPAP volume value of ~50 mL).  Bin sizes are 1%. 
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3.1.2. Developing a Method for Tracking an Abdominal Surface Marker 
Eight 5-minute videos were recorded to verify reproducibility of the tracked circular reflector 
positions.  Each video used different QUASAR phantom oscillation rates and tracked circular 
reflectors.  Reproducibility was quantified using the standard deviation of the abdominal surface 
marker amplitudes for all eight sessions.  The mean abdominal surface marker amplitude, 
calculated by our in-house video analysis code, was 9.66 mm (Figure 3.2.), which was 0.34 mm 
different than the expected amplitude of 10 mm.  The standard deviation of the abdominal surface 
marker amplitudes for all eight sessions was 0.1 mm.   
 
 
 Figure 3.2. Histogram of the calculated abdominal surface marker amplitude values using the 
QUASAR phantom with stated amplitude of 10 mm.  Bin sizes are 0.1 mm. 
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3.2. Aims 2 & 3 Results: Collect and Evaluate Patients’ FB & BIPAP Data 
3.2.1. Overview of Results 
The results of aims 2 and 3, which involved collecting and evaluating patients’ free-breath 
(FB) data and BIPAP ventilation assistance data (Philips BIPAP and Lifecare BIPAP), are 
presented simultaneously.  We collected FB data and BIPAP data from 10 patients during sessions 
which occurred either before or after patients’ radiation treatments.  Not all patients had the same 
number of sessions because patients were prescribed different numbers of radiation treatment 
fractions (Table 2.1.).  Patients were also permitted to skip sessions on treatment days when they 
were not feeling well, running late, or had other appointments (i.e. physician visits, chemotherapy, 
etc.).  We calculated variation metrics for the platform-specific data components and compared 
the results between platforms (i.e. FB vs. Philips BIPAP, FB vs. Lifecare BIPAP, Philips BIPAP 
vs. Lifecare BIPAP).  Statistical significance was determined for each comparison using the non-
parametric Wilcoxon signed-rank test, with a significance level of 0.05.  Patient 8’s results are 
presented first as an example, followed by the results for all patients.  The results are presented in 
the order of: 
• Tidal Volume 
• Abdominal Surface Marker Amplitude 
• Abdominal Surface Marker Period 
• Abdominal Surface Marker Baseline  
• Compilation of Results  
Coefficient of variation (CV) values are unitless quantities and can be thought of as a percent 
variation.  Qualitatively, both intra-session variation figures and inter-session variation figures that 
show lower CV values indicate lower variation (i.e. more reproducible).   
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3.2.2. Tidal Volume 
Intra-session tidal volume variation for each patient was quantified using the mean coefficient 
of variation (CV) of the CVs for all sessions.  Patient 8’s FB, Philips BIPAP, and Lifecare BIPAP 
intra-session tidal volume variation was 0.107, 0.069, and 0.078, respectively (Figure 3.3.).  The 
mean intra-session tidal volume variation of all patients (Figure 3.4.) was 0.172, 0.118, and 0.096 
for FB, Philips BIPAP, and Lifecare BIPAP, respectively.  Both the Philips BIPAP and Lifecare 
BIPAP intra-session tidal volume variations were significantly lower (p = 0.022 and p = 0.007) 
than the FB intra-session tidal volume variation.  The Philips BIPAP had a 0.055 mean variation 
reduction.  The Lifecare BIPAP had the largest mean variation reduction of 0.077.   
Inter-session tidal volume variation for each patient was quantified using the CV of the tidal 
volume session means.  Patient 8’s FB, Philips BIPAP, and Lifecare BIPAP inter-session tidal 
volume variation was 0.094, 0.053, and 0.095, respectively (Figure 3.5.).  The mean inter-session 
tidal volume variation of all patients (Figure 3.6.) was 0.161, 0.106, and 0.113 for FB, Philips 
BIPAP, and Lifecare BIPAP, respectively.  Neither the Philips BIPAP nor Lifecare BIPAP inter-
session tidal volume variations were significantly lower (p = 0.203 and p = 0.074) than the FB 
inter-session tidal volume variation.  The Philips BIPAP had the largest mean variation reduction 
of 0.054.  The Lifecare BIPAP had a mean variation reduction of 0.048.  
3.2.3. Abdominal Surface Marker Amplitude 
Intra-session abdominal surface marker amplitude variation for each patient was quantified 
using the mean coefficient of variation (CV) of the CVs for all sessions.  Patient 8’s FB, Philips 
BIPAP, and Lifecare BIPAP intra-session abdominal surface marker amplitude variation was 
0.087, 0.058, and 0.070, respectively (Figure 3.7.). The mean intra-session abdominal surface 
marker amplitude of all patients (Figure 3.8.) was 0.185, 0.134, and 0.139 for FB, Philips BIPAP, 
and Lifecare BIPAP, respectively.  Neither the Philips BIPAP nor Lifecare BIPAP intra-session 
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 Figure 3.3. Intra-session tidal volume variation for patient 8.  Left:  CV of the tidal volume for 
each session.  Right:  Mean tidal volume CV of all sessions.  This represents the intra-session 
tidal volume variation. 
 
 Figure 3.4. Intra-session tidal volume variation results for all patients.  Black boxes indicate the 
means and white lines indicate the medians.  p-values shown are compared to free-breathe. 
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 Figure 3.5. Inter-session tidal volume variation for patient 8.  Left:  Mean tidal volume of each 
session.  Right:  CV of the tidal volume session means.  This represents the inter-session tidal 
volume variation. 
 
 Figure 3.6. Inter-session tidal volume variation results for all patients.  Black boxes indicate the 
means, white lines indicate the medians, and circles indicate outliers.  p-values shown are 
compared to free-breathe. 
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abdominal surface marker amplitude variations were significantly lower (p = 0.059 and p = 0.114) 
than the FB intra-session abdominal surface marker amplitude variation.  The Philips BIPAP had 
the largest mean variation reduction of 0.051.  The Lifecare BIPAP had a mean variation reduction 
of 0.045.   
Inter-session abdominal surface marker amplitude variation for each patient was quantified 
using the CV of the abdominal surface marker amplitude session means.  Patient 8’s FB, Philips 
BIPAP, and Lifecare BIPAP inter-session abdominal surface marker amplitude variation was 
0.090, 0.087, and 0.094, respectively (Figure 3.9.).  The mean inter-session abdominal surface 
marker amplitude variation of all patients (Figure 3.10.) was 0.254, 0.209, and 0.207 for FB, 
Philips BIPAP, and Lifecare BIPAP, respectively.  Neither the Philips BIPAP nor Lifecare BIPAP 
inter-session abdominal surface marker amplitude variations were significantly lower (p = 0.074 
and p = 0.074) than the FB inter-session abdominal surface marker amplitude variation.  The 
Philips BIPAP had a mean variation reduction of 0.045.  The Lifecare BIPAP had the largest mean 
variation reduction of 0.047. 
3.2.4. Abdominal Surface Marker Period 
Intra-session abdominal surface marker period variation for each patient was quantified using 
the mean coefficient of variation (CV) of the CVs for all sessions.  Patient 8’s FB, Philips BIPAP, 
and Lifecare BIPAP intra-session abdominal surface marker period variation was 0.083, 0.051, 
and 0.045, respectively (Figure 3.11.).  The mean intra-session abdominal surface marker period 
variation of all patients (Figure 3.12.) was 0.140, 0.086, and 0.055 for FB, Philips BIPAP, and 
Lifecare BIPAP, respectively.  Both the Philips BIPAP and Lifecare BIPAP intra-session 
abdominal surface marker period variations were significantly lower (p = 0.022 and p = 0.005) 
than the FB intra-session abdominal surface marker period variation.  The Philips BIPAP had a  
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Figure 3.7. Intra-session abdominal surface marker amplitude variation for patient 8.  Left:  CV of 
the abdominal surface marker amplitude for each session.  Right:  Mean abdominal surface marker 
amplitude CV of all sessions.  This represents the intra-session abdominal surface marker 
amplitude variation. 
 
 Figure 3.8. Intra-session abdominal surface marker amplitude variation results for all patients.  
Black boxes indicate the means and white lines indicate the medians.  p-values shown are 
compared to free-breathe. 
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 Figure 3.9. Inter-session abdominal surface marker amplitude variation for patient 8.  Left:  Mean 
abdominal surface marker amplitudes of each session.  Right:  CV of the abdominal surface 
marker amplitude session means.  This represents the inter-session abdominal surface maker 
variation. 
 
 Figure 3.10. Inter-session abdominal surface marker amplitude variation results for all patients.    
Black boxes indicate the means, white lines indicate the medians, and circles indicate outliers.  p-
values shown are compared to free-breathe. 
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mean variation reduction of 0.054.  The Lifecare BIPAP had the largest mean variation reduction 
of 0.086.  
Inter-session abdominal surface marker period variation for each patient was quantified using 
the CV of the abdominal surface marker period session means.  Patient 8’s FB, Philips BIPAP, 
and Lifecare BIPAP inter-session abdominal surface marker period variation was 0.091, 0.117, 
and 0.011, respectively (Figure 3.13.).  The mean inter-session abdominal surface marker period 
variation of all patients (Figure 3.14.) was 0.143, 0.124, and 0.048 for FB, Philips BIPAP, and 
Lifecare BIPAP, respectively.  The Philips BIPAP inter-session abdominal surface marker period 
variation was not significantly lower (p = 0.169) than the FB inter-session abdominal surface 
marker period variation.  The Lifecare BIPAP inter-session abdominal surface marker period 
variation was significantly lower (p = 0.013) than the FB inter-session abdominal surface marker 
period variation.  The Philips BIPAP had a mean variation reduction of 0.020.  The Lifecare BIPAP 
had the largest mean variation reduction of 0.095.   
3.2.5. Abdominal Surface Marker Baseline 
Intra-session abdominal surface marker baseline variation for each patient was quantified using 
the mean standard deviation (SD) of the SDs for all sessions.  Patient 8’s FB, Philips BIPAP, and 
Lifecare BIPAP intra-session abdominal surface marker baseline variation was 0.787 mm, 0.352 
mm, and 0.577 mm, respectively (Figure 3.15.).  The mean intra-session abdominal surface marker 
baseline of all patients (Figure 3.16.) was 0.725 mm, 0.682 mm, and 0.945 mm for FB, Philips 
BIPAP, and Lifecare BIPAP, respectively.  The Philips BIPAP intra-session abdominal surface 
marker baseline variation was not significantly lower (p = 0.646) than the FB intra-session 
abdominal surface marker baseline variation.  The Lifecare BIPAP intra-session abdominal surface 
marker baseline variation was significantly higher (p = 0.037) than the FB intra-session abdominal 
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 Figure 3.11. Intra-session abdominal surface marker period variation for patient 8.  Left:  CV of 
the abdominal surface marker period for each session.  Right:  Mean abdominal surface marker 
period CV of all sessions.  This represents the intra-session abdominal surface marker period 
variation. 
 
 Figure 3.12. Intra-session abdominal surface marker period variation results for all patients.   
Black boxes indicate the means, white lines indicate the medians, and circles indicate outliers.  
p-values shown are compared to free-breathe. 
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 Figure 3.13. Inter-session abdominal surface marker period variation for patient 8.  Left:  Mean 
abdominal surface marker periods of each session.  Right:  CV of the abdominal surface marker 
period session means.  This represents the inter-session abdominal surface marker period 
variation. 
 
 Figure 3.14. Inter-session abdominal surface marker period variation results for all patients.  Black 
boxes indicate the means, white lines indicate the medians, and circles indicate outliers.  p-values 
shown are compared to free-breathe. 
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surface marker baseline variation.  The Philips BIPAP had the largest mean variation reduction of 
0.043 mm.  The Lifecare BIPAP had an increase in mean variation of 0.220 mm. 
3.2.6. Compilation of Results 
Overall, the Philips BIPAP reduced intra-session and inter-session mean variations for all data 
components compared to FB (Figure 3.17. and Figure 3.18.); however, only the intra-session tidal 
volume variation and intra-session abdominal surface marker period variation were significantly 
lower than the corresponding FB variations (Table 3.1.).  The mean ± one SD Philips BIPAP data 
collection time (first abdominal surface marker peak time to last abdominal surface marker peak 
time) of all patients was 110.5 ± 6.8 sec.  This was not significantly different (p = 0.721) than the 
mean ± one SD FB data collection time of 112.0 ± 5.0 sec.   
Overall, the Lifecare BIPAP reduced intra-session and inter-session mean variations for all 
data components except the intra-session abdominal surface marker baseline, compared to FB 
(Figure 3.17. and Figure 3.18.); however, the intra-session tidal volume variation and both the 
intra-session and inter-session abdominal surface marker period variations were significantly 
lower than the corresponding FB variations (Table 3.1.).  The intra-session abdominal surface 
marker baseline variation was significantly higher than the corresponding FB variation.  The mean 
± one SD Lifecare BIPAP data collection time (first abdominal surface marker peak time to last 
abdominal surface marker peak time) of all patients was 75.8 ± 24.3 sec.  This was significantly 
lower (p = 0.005) than the mean ± one SD FB data collection time of 112.0 ± 5.0 sec.   
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 Figure 3.15. Intra-session abdominal surface marker baseline variation for patient 8.  Left:  SD of 
the abdominal surface marker baseline for each session.  Right:  Mean SD of the abdominal 
surface marker baselines of all sessions.  This represents the intra-session abdominal surface 
marker baseline variation. 
 
 Figure 3.16. Intra-session abdominal surface marker baseline variation results for all patients.    
Black boxes indicate the means, white lines indicate the medians, and circles indicate outliers.  p-
values shown are compared to free-breathe. 
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 Figure 3.18. Summary of inter-session variation results.  Black boxes indicate the means, white 
lines indicate the medians, and circles indicate outliers.  p-values shown are compared to free-
breathe. 
 
 Figure 3.17. Summary of intra-session variation results, excluding the abdominal surface baseline 
results.  Black boxes indicate the means, white lines indicate the medians, and circles indicate 
outliers.  p-values shown are compared to free-breathe. 
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 Intra-session variation Inter-session variation 
 Tidal Volume ASM
◊ 
Amplitude ASM
◊ Period ASM◊ Baselineµ Tidal Volume ASM
◊ 
Amplitude ASM
◊ Period 
 FB#$-P#$ FB#$-L#$ FB#$-P#$ FB#$-L#$ FB#$-P#$ FB#$-L#$ FB()-P() FB()-L() FB#$-P#$ FB#$-L#$ FB#$-P#$ FB#$-L#$ FB#$-P#$ FB#$-L#$ 
1 0.080 0.130 0.122 0.134 0.086 0.157 0.064 -0.997 0.035 0.045 0.121 0.114 0.029 0.141 
2 0.154 0.176 0.183 0.149 0.214 0.233 -0.024 -0.002 0.153 0.110 0.203 0.150 0.059 0.142 
3 0.022 0.025 0.019 0.001 0.037 0.065 0.383 0.210 -0.088 -0.007 -0.016 -0.005 -0.028 0.035 
4 0.017 0.020 -0.000 0.058 0.017 0.047 -0.559 -0.315 0.077 0.029 0.052 0.067 0.093 0.113 
5 0.041 0.104 0.008 0.031 -0.012 0.045 0.109 -0.009 0.022 0.051 -0.048 -0.008 -0.055 -0.050 
6 -0.016 -0.010 -0.014 -0.062 0.006 0.000 -0.071 -0.326 -0.052 -0.007 -0.017 -0.001 -0.006 0.009 
7 0.033 0.047 0.014 0.001 -0.014 0.033 -0.156 -0.298 0.096 -0.024 0.074 0.015 0.047 0.072 
8 0.038 0.028 0.029 0.017 0.032 0.039 0.435 0.210 0.041 -0.002 0.002 -0.004 -0.026 0.081 
9 0.203 0.197 0.164 0.160 0.129 0.162 -0.010 -0.390 0.298 0.233 0.064 0.112 0.042 0.232 
10 -0.025 0.047 -0.016 -0.035 0.044 0.074 0.259 -0.280 -0.038 0.047 0.018 0.030 0.041 0.178 
Mean 0.055 0.077 0.051 0.045 0.054 0.086 0.043 -0.220 0.054 0.048 0.045 0.047 0.020 0.095 
p-
value 0.022 0.007 0.059 0.114 0.022 0.005 0.646 0.037 0.203 0.074 0.074 0.074 0.169 0.013 
BOLD indicates statistical significance 
◊ Abdominal Surface Marker (ASM) 
µ Difference in mm 
    
 Table 3.1. Statistical summary of results for all patients (1-10).  CV difference (unless otherwise indicated) from FB shown.  Green 
indicates a variation reduction.  Red indicates a variation increase.  P indicates the Philips BIPAP and L indicates the Lifecare BIPAP.  
Statistical significance was determined for each comparison (FB vs. Philips BIPAP and FB vs. Lifecare BIPAP) using the non-
parametric Wilcoxon signed-rank test, with a significance level of 0.05. 
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Comparing the two BIPAPs against each other shows mixed results.  The Philips BIPAP had 
significantly lower intra-session abdominal surface baseline variation compared to the 
corresponding Lifecare BIPAP variation.  The Lifecare BIPAP had significantly lower intra-
session tidal volume variation, intra-session abdominal surface marker period variation, and inter-
session abdominal surface marker period variation than the Philips BIPAP (Table 3.2.). 
 
 Intra-Session Variation Inter-Session Variation 
 Philips Lifecare p-value Philips Lifecare p-value 
Tidal 
Volume  
CV (SD) 
0.118 (0.047) 0.096 (0.024) 0.047 0.106 (0.063) 0.113 (0.029) 0.799 
ASM◊ 
Amplitude 
CV (SD) 
0.134 (0.070) 0.139 (0.058) 0.386 0.209 (0.096) 0.207 (0.074) 0.575 
ASM◊ Period 
CV (SD) 0.086 (0.031) 0.055 (0.013) 0.007 0.124 (0.047) 0.048 (0.046) 0.005 
ASM◊ 
Baselineµ 
SD (SD) 
0.682 (0.262)  0.945 (0.384) 0.037    
BOLD indicates statistical significance 
◊ Abdominal Surface Marker (ASM) 
CV:  Coefficient of variation 
SD:  Standard deviation 
µ Units are mm 
  
 Table 3.2. Statistical comparison of the Philips BIPAP to the Lifecare BIPAP.  Mean CV values 
(unless otherwise indicated) of all patients are displayed.  Statistical significance was determined 
for each comparison using the non-parametric Wilcoxon signed-rank test, with a significance 
level of 0.05. 
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4.  Discussion 
4.1. Summary of Findings 
This study evaluated using BIPAP ventilation assistance to help patients improve their 
respiratory reproducibility.  In Aim 1, we modified equipment which allowed us to collect patients’ 
breathing data.  In Aims 2 and 3, we collected and evaluated patients’ free-breathe (FB) and BIPAP 
ventilation-assisted breathing data.  Data components of each platform (i.e. FB, Philips BIPAP, 
and Lifecare BIPAP) included the tidal volumes, and abdominal surface marker amplitudes, 
periods, and baselines.  We calculated and compared intra-session (breath-to-breath) and inter-
session (day-to-day) variations of the FB and BIPAP breathing data components to evaluate 
respiratory reproducibility.   
Based on the high correlation of respiratory volume (i.e. tidal volume) to tumor motion,16 we 
assumed that the tidal volume was an acceptable surrogate for tumor motion.  We also used an 
abdominal surface marker to provide a monitoring system that was independent of the tidal volume 
measurements and consistent across both the FB and BIPAP ventilation data collection platforms.  
We used the abdominal surface marker amplitudes, periods, and baselines to provide spatial and 
temporal information about the respiration pattern.   
We observed that patients’ FB tidal volume respiratory patterns demonstrated both intra-
session and inter-session variations.  Dosimetrically, breath-to-breath and day-to-day tumor 
motion variations could alter the tumor coverage or require larger treatment margins to ensure full 
tumor coverage.  The negative consequences of tumor motion variations could include 
overexposing normal tissues or worse, underexposing the tumor.  Thus, it is crucial that patients 
reduce tidal volume respiratory pattern variations.  Our results showed that BIPAP ventilation 
assistance reduced both intra-session and inter-session tidal volume variations, compared to 
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unassisted free-breathing; however, only the intra-session tidal volume variation was significantly 
reduced.  Although no studies have previously investigated using BIPAP ventilation assistance to 
improve respiratory reproducibility, our intra-session findings are consistent with a similar 
respiratory reproducibility study by Lim et al.17  Their results included significant (p < 0.05) 
reductions in the intra-session standard deviations of the tidal volumes by providing visual 
feedback of the real-time breathing pattern to 10 healthy volunteers.  The reductions in intra-
session and inter-session tidal volume variation with BIPAP ventilation assistance could lead to 
improvements in both image quality during image acquisition and radiation treatment accuracy 
during radiation delivery;15 however, the magnitude of these improvements needs to be 
investigated.  We can translate our results to an estimation of the reductions in tumor motion 
variation by making a few assumptions such as a mean tumor motion of 1-3 cm and a one-to-one 
correlation between tidal volume and tumor motion.4, 16  These assumptions indicate that a 0.06 
tidal volume CV reduction (mean of BIPAPs intra-session and inter-session CVs) could result in 
a 0.1-0.2 cm reduction in tumor motion variation (i.e. standard deviation).  This improvement in 
respiratory reproducibility could lead to the tumor being in the PTV more during radiation delivery 
or even a reduction of the PTV margins added using the motion-encompassing methods, which 
currently are 0.2-0.5 cm.24   
Analogous to our tidal volume respiratory pattern observations, patients’ FB abdominal surface 
marker amplitudes, periods, and baselines demonstrated both intra-session and inter-session 
variations.  We found that BIPAP ventilation assistance reduced both intra-session and inter-
session abdominal surface marker amplitude and period variations, compared to unassisted FB, 
although only the period variations were significantly lower.  A similar observation has been 
documented by Neicu et al., who suggests that a reproducible abdominal surface marker period is 
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required to predict tumor position and synchronize the radiation field to the tumor motion.25, 26  
The significant reductions in intra-session and inter-session abdominal surface marker period 
variations with BIPAP ventilation assistance could lead to improvements in tumor position 
predictions or even in respiratory gating techniques where reproducible tumor motion periods are 
desirable. 
The pure ventilation characteristics (i.e. permits patient triggering) of the Philips BIPAP 
required that patients actively control their respiratory pattern.  The use of the Philips BIPAP was 
well-tolerated and none of the patients mentioned any discomfort.  The controlled ventilation 
assistance characteristics (i.e. does not permit patient triggering) of the Lifecare BIPAP provided 
more control of the tidal volume each breath, compared to the Philips BIPAP; however, patients 
were still required to synchronize their breathing pattern to the fixed air volume output of the 
Lifecare BIPAP.  Some patients had difficulty using the Lifecare BIPAP, especially breathing at 
the fixed breathing period, and ultimately could not use it for more than a short amount of time.  
The use of the Lifecare BIPAP was tolerated, although not as well as the Philips BIPAP.  Most of 
the patients that had trouble using the Lifecare BIPAP mentioned that it felt restrictive or that their 
breaths were “cut off.”  We attribute these problems to our coaching methods (e.g. only using 
green “inhale” and red “exhale” visual cues) and imperfect patient-specific Lifecare BIPAP 
ventilator settings (i.e. breathing periods), which were determined during the first session and used 
for subsequent sessions.   
After comparing the Philips BIPAP against the Lifecare BIPAP, it is not clear which is the best 
at improving respiratory reproducibility.  We believe that combining certain capabilities of each 
BIPAP, specifically the air volume output limit of the Lifecare BIPAP and the adaptive Auto-Trak 
Sensitivity of the Philips BIPAP (1.1.7 Bi-Level Positive Airway Pressure (BIPAP) Ventilation), 
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would result in even lower intra-session and inter-session variations.  The mixed results, in 
addition to patients’ comments, indicate that developing a hybrid BIPAP, with capabilities of the 
Philips BIPAP and Lifecare BIPAP, would be the logical next step. 
4.2. Response to Hypothesis 
The Philips BIPAP and Lifecare BIPAP intra-session tidal volume variation was significantly 
reduced compared to unassisted free-breathe, which supported the hypothesis.  
The Philips BIPAP and Lifecare BIPAP inter-session tidal volume variation was reduced, 
although not significantly compared to unassisted free-breathe, which did not support the 
hypothesis.  
4.3. Limitations of This Study 
This study has several limitations beyond using a small sample size of 10 patients.  These 
limitations include patients missing or skipping sessions on treatment days, Lifecare BIPAP data 
collection times for some patients, short data collection times relative to typical treatment times, 
the placement of the abdominal surface marker each session, a Philips BIPAP volume waveform 
calculation issue, and an imperfectly sealed Lifecare BIPAP patient circuit. 
Patients participated in daily sessions which occurred either before or after their radiation 
therapy treatments.  All patients had sessions on more than 50% of their treatment days; however, 
patients were permitted to skip sessions on treatment days when they were not feeling well, running 
late, or had other appointments (i.e. physician visits, chemotherapy, etc.).  Subsequently, the 
overall impact of using ventilation assistance was not fully investigated, which would have 
required having sessions on all treatment days.   
Seven patients did not have mean Lifecare BIPAP data collection times longer than 90 seconds.  
The patients that had difficulty could not use it for more than a short amount of time before they 
had to open their mouth and “catch their breath.”  During the first session, the Lifecare BIPAP 
 52 
data collection ended if patients had to open their mouth to catch their breath or if they notified the 
investigator that they could not follow the Lifecare BIPAP any longer.  On subsequent sessions, 
patients were expected to match the data collection times from their first session.  
We collected breathing data during two-minute intervals, which simulated a typical volumetric 
modulated arc therapy radiation treatment beam-on time.  In reality, typical treatment sessions can 
last up to and beyond 30 minutes due to patient setups, daily imaging, and multiple radiation 
beams.  Based on the feedback from patients in this study and the data collection time results for 
the Lifecare BIPAP, requiring patients to use BIPAP ventilation assistance throughout the entire 
treatment session is most likely not feasible.  Instead, a relief valve could be inserted into the 
patient circuit that would permit patients to breathe freely during times when they are not required 
to use the BIPAP (e.g. time between patient setup and daily imaging). 
The abdominal surface marker was placed midway between the xiphoid process and umbilicus 
and rested on a thin piece of acrylic.  Indexing on the couch was used to ensure abdominal surface 
marker placement reproducibility for each session; however, patients could have been lying on the 
couch slightly angled or rotated (i.e. patient’s abdominal surface was not normal to the abdominal 
surface marker) from session to session.  These differences in abdominal surface marker 
positioning would have led to a systematic inflation of the inter-session amplitude variation for 
FB, Philips BIPAP, and Lifecare BIPAP.  Intra-session abdominal surface marker amplitude 
variation would not have been impacted by any differences in abdominal surface marker 
positioning. 
The Philips BIPAP provided an LCD color touchscreen that displayed the real-time volume 
waveform.  Functionally, the Philips BIPAP monitors the real-time flow and calculates the real-
time volume using numerical integration.  The real-time inhalation volume is calculated while the 
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monitored flow is positive.  During this time, the BIPAP applies the inhalation pressure.  Once the 
Philips BIPAP senses that the user has ceased inhalation, it reduces the pressure.  During this time, 
the BIPAP applies the exhalation pressure.  The calculation of the inhalation volume is 
subsequently stopped (i.e. inhalation volume has achieved its maximum value).  If the Philips 
BIPAP falsely senses that the patient has ceased inhalation, meaning that the patient continues to 
inhale even though the Philips BIPAP has reduced the pressure, the displayed volume value will 
be incorrect.  The root of the problem is the sensitivity of the Philips BIPAP’s Auto-Trak 
Sensitivity feature, which monitors when the user has ceased inhalation.  Unfortunately, we were 
not able to adjust the sensitivity.  This error was accounted for by recording and monitoring both 
the real-time flow and volume waveforms.  If the flow waveform indicated the patient continued 
to inhale and the volume waveform achieved its maximum value or “flat-lined”, the breath was 
ignored.  In total, 4.9% of all breaths using the Philips BIPAP were ignored because of this issue. 
The Lifecare BIPAP patient circuit consisted of a six-foot-long, ¾" diameter piece of flexible 
plastic tubing which connected the BIPAP air output port to the patient’s nasal mask.  A water 
solenoid valve was inserted into the circuit to permit patient exhalation.  Unfortunately, the patient 
circuit was not a completely sealed circuit.  Air could be inhaled, if forcefully enough, through the 
one-way water solenoid valve.  This unavoidable leak in the patient circuit system was a 
consequence of our experimental design and could have resulted in increased intra-session and 
inter-session tidal volume variations for the Lifecare BIPAP.   
4.4. Future Work 
The results of this study warrant future work into the possible clinical benefits of BIPAP 
ventilation assistance.  This work should include developing a hybrid BIPAP ventilator, 
performing a healthy volunteer study to assess their variation reductions and receive coaching 
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feedback, and performing an investigation of the impact on tumor motion variations using BIPAP 
ventilation assistance.   
Our results showed that variations in respiratory patterns were reduced using BIPAP 
ventilation assistance.  Comparing the Philips BIPAP against the Lifecare BIPAP showed mixed 
results about which one was better, indicating that developing a hybrid BIPAP would be the best 
next step.  Ideally, the simplest solution to combining the useful attributes of both BIPAPs would 
be to limit the volume of air output by the Philips BIPAP each breath, similar to the Lifecare 
BIPAP.  Unfortunately, after discussions with Philips, there seems to be little to no possibility of 
implementing a “tidal volume limit feature” in the Philips BIPAP.  Newer models of the Lifecare 
BIPAP, specifically the Lifecare PLV 102b, come standard with a mode named Synchronized 
Intermittent Mandatory Ventilation (SIMV) mode.  In the SIMV mode, the ventilator delivers a 
minimum breathing rate at a preset tidal volume; however, the patient may breathe spontaneously 
at a rate higher than at the set level.  We hypothesize that utilizing this mode would alleviate some 
of the difficulty in using the Lifecare BIPAP by allowing patients to breathe spontaneously, 
similarly to the Philips BIPAP, but still have a preset tidal volume output.  Further investigation 
and research is needed to assess the possibility of using a newer model of the Lifecare BIPAP.   
This study collected and evaluated ventilation assistance data on patients, who are the intended 
users of BIPAP ventilation assistance.  Patient compliance was necessary to use both the Philips 
BIPAP and Lifecare BIPAP successfully.  Performing a similar study on healthy volunteers, who 
would represent ideal compliance, would hopefully reveal the best possible intra-session and inter-
session variation achievable with BIPAP ventilation assistance.  Feedback could also be obtained 
to aid in improving our coaching method.   
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The results of this study show that respiratory variations were reduced with BIPAP ventilation 
assistance.  Because tidal volume highly correlates to tumor motion, an investigation is needed to 
determine the reduction in tumor motion variations using BIPAP ventilation assistance.  This 
investigation would shed light on the possible clinical benefits of using BIPAP ventilation 
assistance. 
4.5. Conclusion 
This study tested the feasibility of using BIPAP ventilation assistance to help patients improve 
their respiratory reproducibility.  The results showed that variations in respiratory patterns were 
reduced using BIPAP ventilation assistance.  Reducing variations of the respiratory patterns could 
reduce variations of tumor motion.  Future work will include an investigation into the possible 
clinical benefits of using ventilation assistance to reduce tumor motion variations.  
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Appendix A. Institutional Review Board Protocol 
 
 
Our Lady of the Lake College IRB Study number 2018-029 
Amendment 2 Approved:  14-SEP-2018 
 
A Pilot Study for the First Augmented Ventilation for Reproducible Respiration Evaluation 
Mary Bird Perkins – Our Lady of the Lake Cancer Center 
 
Purpose/Background:   
For cancers specifically located in the lung and abdomen, radiation therapy can be complicated by 
tumor motion due to breathing.  Radiation treatment planning typically relies on a series of 3D 
computed tomography images to document tumor motion, location and shape throughout the 
respiratory cycle.  This technique is referred to as 4DCT.  These patients, throughout the 4DCT imaging 
process, are coached to maintain normal breathing efforts.  However, many patients fail to maintain the 
same regular, reproducible breathing pattern during subsequent treatments.   The images obtained 
during the 4DCT are used during radiation treatment planning to achieve 2 goals: (1) enlarge the 
planning target volume (PTV) to account for uncertainties which, in this case, include an increased safety 
margin due to the potential breathing variability during treatment and (2) minimize a PTV, which is 
exposed to high prescription doses, to spare the surrounding healthy tissue as much as possible, thus 
reducing radiation induced side effects and toxicity.  It has been a primary objective during the 
treatment planning process to achieve goal 2 while not sacrificing goal 1.  Achieving a better balance 
between the two may result in improved outcomes for many patients. 
Currently in the field of radiation therapy, breathing is not typically monitored for most patients, and 
there is no effective solution for patients who would benefit from PTV reduction but are unable to 
maintain consistent breathing patterns.  The purpose of this pilot research study is to assist patients in 
producing a more consistent breathing pattern during the 4DCT imaging process and each subsequent 
treatment.  This consistency in breathing, achieved through bi-level ventilation, will ensure the patient 
tumor motion is reproducible throughout the course of treatment, helping to improve the healthy tissue 
sparing through reduction in PTV margins and potential to support more effective “gated” radiation 
delivery strategies in the future. 
Design:   
Equipment and phase of Study: 
Through the use of a non-invasive assisted breathing device, a program will be established that utilizes a 
combination of coaching and the breathing device to improve a patient’s breathing reproducibility 
during imaging and treatment.  We intend to utilize and adapt a full featured Bilevel Positive Airway 
Pressure (BPAP) machine for this project.  A Philips Respironics V60 non-invasive BPAP ventilator will be 
used for the first of a two phase project.  
Those undergoing a 4DCT, typically lung patients are eligible to participate in the trial. 
The initial pilot phase of the project will be concentrated on establishing patient training procedures, 
ventilation parameter optimization and augmented reproducibility of respiration in the imaging suite 
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and treatment planning stages. Each patient will have a recording session for each daily treatment using 
the equipment to practice/track reproducibility.  
Healthy subjects (ie, volunteers without cancer) are also eligible to participate  in the trial.  Healthy 
subjects will have zero ionizing radiation and will solely be used as a comparison group (ie, establishing a 
baseline) of using the non-invasive BPAP.  
The second phase of the project will focus on implementation in treatment delivery rooms. The existing 
BPAP equipment used in the first phase above will not be used for treatment as it is not specifically 
adapted to the requirement of radiation treatment conditions which require remote control and 
monitoring. This will require additional funding for equipment modification or the design must be 
adapted specific to treatment delivery room needs The second phase will depend on the outcome of the 
pilot phase of study and available funding. 
 
Eligibility Criteria: 
 
x Patients:Patients with pathological or cytological proven lung carcinoma 
x Must be able to speak and understand English 
x ≥ 18 years of age 
x Presenting to cancer center for fractionated radiation therapy requiring a 4DCT imaging 
procedure and to be treated with normal breathing during treatment as ordered by a 
participating radiation oncologist   
x Patients must be non-claustrophobic and able to  tolerate wearing a ventilation mask  
x Patients must be amenable to coaching.  
x Patients that require nasal oxygen cannula assist are also eligible. 
Healthy Subjects: 
x Volunteer without cancer and a non-smoker 
x Must be able to speak and understand English 
x >= 18 years of age 
x Healthy subjects must be non-claustrophobic and able to tolerate wearing a ventilation mask 
x Healthy subjects must be amenable to coaching.  
Study Randomization: 
The patient is asked to match the breathing pattern he/she establish during imaging used for radiation 
planning. If the patient with breathing assistance can repeat the same respiration pattern during each 
session/treatment, it is definitively 100% successful. Each patient is his/her own control when not using 
the breathing assistance. 
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Similar to patient data collection, healthy subjects breathing will be recorded during daily sessions, with 
and without ventilation assistance.  The healthy subject will act as his/her own control. 
This non-randomized pilot study will be aimed as efficacy of active assistance in reproducibility of 
patient breathing during all fractionated treatments matching as close as the initial 4DCT image scan 
captured at one point in time with a particular state of patient’s normal breathing upon which a 
radiation plan was designed. Before each daily treatment over the course of fractionated radiation 
therapy, a recording of “warmup” session of the same patient with and without active breathing 
assistance is its own study and control comparison.  
 
Sample Size: 
The expected enrollment for this study is 30 total participants overall (20 cancer patients and 10 healthy 
subjects). 
 
Methods:   
Patients who report to the Mary Bird Perkins-Our Lady of the Lake Cancer Center Radiation Oncology 
Center for radiation treatment planning with a cancer diagnosis will be eligible for this study.  Only 
English speaking patients will be included.  The principal investigator (PI) will identify potential patients 
for the study through computer review of the weekly schedule.  Potential subjects will be approached by 
the PI for discussion of informed consent and study participation usually on the day of the initial patient 
consult by the radiation oncologist.  The informed consent discussion will take place in a private exam 
room.  To avoid any implication of coercion, the treating radiologist will not be involved in any aspect of 
the consenting process.    Potential patients will be instructed that declining participation in this pilot 
study will in no way affect their radiation treatment plan.  The study will be conducted starting at the 
initial Imaging simulation day. 
Healthy subjects who approach or contact the PI about volunteering for this study will be eligible.  The PI 
will make the study known by posting a flyer in the radiation oncology department in addition to word-
of-mouth.  Healthy subjects that contact the PI about the study will have a discussion of informed 
consent.  No monetary compensation will be given to healthy subjects that volunteer. 
For cancer patients - The study will involve the following steps: 
1. At the initial 4DCT imaging stage, the patient will be coached to establish a natural breathing 
pattern. An inhale/exhale ventilation pattern will be customized to closely match it. The patient 
is expected to wear a BPAP ventilation mask, per manufacturer’s guidelines during the whole 
process. Note, the low bi-level pressure air-flow ventilation is non-invasive in nature, i.e., it is a 
voluntary inhale/exhale process.  
2. The patient will practice the customized breathing pattern until it can be matched consistently.   
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3. The patient will go through the normal patient immobilization simulation setup on the CT couch. 
4.  A 4DCT imaging scan will be done with the patient wearing the BPAP mask and breathing the 
fixed ventilation pattern. Note the patient does not have to follow the driving pattern but only 
as required as follows.   It is expected the patient to breath and match the ventilation pattern 
consistently only during the CT scanning time of 1-2 minute intervals. The patient will be 
prompted to start and will ramp up to breathing consistency after a few breath cycles before the 
“beam” turn on. 
5. The patient is expected to practice with the equipment for about 10-15 minute session before 
each treatment time if the patient is not asked to use the BPAP machine during treatment. All 
such arrangements will be done ahead of time to avoid patient scheduling confusion. 
6. Depending on the stage of our study (2nd stage), the patient may be asked to use the BPAP 
machine during all radiation treatments. If so, it is expected for the patient to follow the 
breathing pattern consistently during radiation beam-on time of 1-2 minute intervals. There may 
be between 5-10 intervals of such beam-on demands during each treatment.  
 
For healthy subjects the study will involve the following steps: 
1. During the first session, the healthy subject will first go through normal patient immobilization 
simulation setup on the CT couch.  This process is only needed to create an immobilization 
device that the healthy subjects will use during subsequent sections. 
2. The healthy subject will be coached to establish a natural breathing pattern.  An inhale/exhale 
ventilation pattern will be customized to closely match it.  The healthy subject is expected to 
wear a BPAP ventilation mask, per manufacturer’s guidelines during the whole process.  Note, 
the low bi-level pressure air-flow ventilation is non-invasive in nature, i.e., it is a voluntary 
inhale/exhale process. 
3. The healthy subject is expected to practice with the equipment for about 10-15 minutes during 
daily sessions. 
Informed consent will be obtained by Connel Chu or a staff member who has been trained in research 
procedures under the direction of Dr. Mr. Chu.  The informed consent will be signed by the patient or 
legally authorized representative as well as the person obtaining consent. 
Analysis Methods: 
The principal investigator will analyze patient breathing patterns through the use of a BPAP machine 
that has been adapted for this research study. 
Data points will be based on respiration volume per cycle. There will be # of respiration cycles in 1-2 
minute period for each fractionation in a fractionated course per patient. The patient’s classification will 
be normalized to lung differential (inhale/exhale) volume per tumor motion distance. 
 
Analysis will be respiration volume variance per cycle, per fraction of 1-2minute period, per daily 
fractions all correlated to tumor movement distance. 
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Appendix B. Calculating Volume from Flow Signal 
Free-breathe volume data and Lifecare BIPAP volume data was recorded using the Sensirion 
SFM 3000 mass flow meter (Sensirion AG, Switzerland) shown in Figure 2.9., which uses 
complementary metal-oxide-semiconductor (CMOS) technology to measure air flow at rates up to 
200 standard liters per minute (slm) and with an accuracy of ± 0.05 slm.  The SFM 3000 flow 
meter was connected to the same dedicated computer as the camera for the Philips BIPAP.  Under 
software control, the sensor sampled the air flow approximately every eight milliseconds and 
logged the flow signal in a comma separated variable file.   
The flow signal (Figure B.1.) was integrated using the cumulative trapezoidal numerical 
integration (cumtrapz) function in MATLAB®.  The cumtrapz function computes the approximate 
cumulative integral of the input (i.e. flow signal) via the trapezoidal method with non-uniform 
spacing (i.e. flow signal sample time) and outputs the result (i.e. raw volume).   
 
 
 Figure B.1. Example of recorded flow signal. 
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Linear trends were often observed in the raw volume (Figure B.2.).  These linear trends resulted 
from an imperfectly sealed system (i.e. slight leaks around the nasal mask) and were removed from 
the raw volume using the detrend function in MATLAB®.  The detrend function computes the 
least-squares fit of a straight line to the input data (i.e. raw volume) and subtracts the resulting 
linear function from the input data.  The raw volume was manually cut to only include the data 
that was analyzed (i.e. from recording start (notification to patient) to end) and then was detrended.  
The detrended volume was further processed to have every breath start at zero (Figure B.3.).  Each 
breath’s tidal volume value was determined by calculating the volume amplitude of each breath or 
the exhale volume amount.  We validated our flow signal to volume calculation method using a 
3L calibration syringe. 
 
 
 Figure B.2. Raw volume calculated by integrating the corresponding flow signal from Figure 
B.1. 
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 Figure B.3. Post-processed volume.  The black asterisks indicate the tidal volume of each breath. 
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